It appears that the activity of insulin hinders the synthesis of glycogen in the liver, and at the same time, the gluconeogenesis pathway affects the concentration of blood sugar in many respects, eventually causing metabolic diseases such as hyperglycemia and hyperlipidemia [29]. The gene discussed is INS; the disease is metabolic disease.